1099 compounding sales jobs in Colorado, Georgia, Iowa, Indiana, Kansas, New Mexico, New Jersey, Minnesota, Missouri, Nevada, New York, Oklahoma, Texas, Washington

1099 Pharmaceutical Representative

Dallas, TX

 

---

NVYDiA Medical - Pharmaceutical Compound SalesIf you are currently in Pharmaceutical or Medical Sales and have established relationships with physicians (Primary Care, Internal Medicine, Neuro's, Ortho's, Plastic's, Podiatrists, Chronic Pain, Spine, Radiation Oncology, Hospice, Urology, Hand Surgeons, Lower/upper Extremity, Sports Medicine, Rheumatology, Rehabilitation, etc.) this is a great opportunity for you.This is not a position you have to leave your current job for. This is an opportunity for you to supplement your income with an additional revenue stream added to your existing salary.  This opportunity can increase your yearly income without you going outside of your call pattern, if you have existing relationships.  If you have solid contacts in medical, pharmaceutical or other healthcare industries, send your resume and we will contact you.Below is a general description of what you will be offering your physicians:First, we offer everyday used injectable drugs that are administered with in the clinic, for example, B-12, steroid injections, Testosterone injections, antibiotic injections, etc.  Our business model has cut out the middle man to offer these products at a discounted price.  What makes this sale so easy, is that we are offering products that the doctors or clinics are purchasing, we are just helping them save money.Second, pharmaceutical compounding, (done in compounding pharmacies) is the creation of a particular pharmaceutical product to fit the unique needs of a patient. To do this, compounding pharmacists combine or process appropriate ingredients using various tools. This may be done for medically necessary reasons, such as to change the form of the medication from a solid pill to a liquid, to avoid a non-essential ingredient that the patient is allergic to, or to obtain the exact dose needed. More recently it has been suggested that some doctors and clinics have turned away from major drug manufacturers and turned to compounding pharmacies because they often provide a much higher quality of product and charge much lower prices than the major manufacturers.Positions available in:  Colorado, Georgia, Iowa, Indiana, Kansas, New Mexico, New Jersey, Minnesota, Missouri, Nevada, New York, Oklahoma, Texas, WashingtonFor those who meet the qualifications and are interested, send your resume to: resumes@nvydiamedical.com

Kansas Adopting New Rules and Regulations, Hiring and Training Inspector, Additional Inspections for Holders of Nonresident Permit in Another State

Compounding Issues
Last year’s deadly outbreak of fungal meningitis linked to
spinal injections of a pain-relieving steroid product produced
by the New England Compounding Center in Massachusetts
raised serious questions about the oversight of compounding
pharmacies and the appropriate role for federal and state
regulators. The Kansas State Board of Pharmacy and Kansas
Department of Health and Environment participated in a Food
and Drug Administration (FDA) intergovernmental meeting on
December 19, 2012. There was discussion on whether the states
had the resources to provide oversight of pharmacy compounding
and whether there was a way to rebalance federal and state
participation in the regulation of pharmacy compounding that
would better protect the public health.
The Board is very concerned about whether federal preemptions
will be enacted that could possibly undermine the
Board’s authority by removing its oversight in this area. The
Board has implemented a plan that includes the adoption of
rules and regulations for compounding. The regulations have
been approved by the Department of Administration and are
currently at the Office of the Attorney General for review. The
Board has asked the Office of the Attorney General to expedite
these regulations. The inspectors are going to receive additional
training related to compounding, and the Board is going to
work with the National Association of Boards of Pharmacy®
and other states to share its limited resources. The Board has
also requested that Board staff seek approval for hiring an
additional pharmacist inspector.
If you hold a nonresident permit in another state, be advised
that your pharmacy may get an additional inspection from the
state in which you are licensed. Make sure that you know the
laws of each state that you are registered in related to office use
because many states do not allow this practice. The Board will
cooperate with any state that wants an additional inspection of
your premises.
It is the Board’s goal to address the compounding issues in
order to adequately protect the public’s health, welfare, and
safety.
Source Kansas Board of Pharmacy March 2013 Newsletter

Office Use in Kansas

Office Use Prescriptions
The Board has been asked on occasion whether
an “office use” prescription is valid. The answer is
no. Medications prescribed must be dispensed to a
patient. When medication is sent from a pharmacy to a
practitioner for administration, the transfer is considered
a distribution.
The transfer of a prescription medication is permitted
from one pharmacy to another pharmacy or practitioner.
The transfer must be documented with an invoice record.
The invoice record must have the name, strength, form of
the medication, the name and address of both the seller
and the purchaser, and the date of the sale. This record
should be maintained for five years with your pharmacy
records.
If the transfer is a controlled substance, the invoice
must also include the DEA number of both the seller
and the purchaser. If the medication is a Schedule II
medication, the purchaser must provide a DEA Form 222
to the seller before the transfer is completed.
A retail pharmacy may transfer prescription drugs to
another retail pharmacy to alleviate a temporary shortage,
except that the gross dollar value of these transfers
shall not exceed 5% of the total prescription-only drug
sales revenue of either the transferor or the transferee
pharmacy during any period of 12 consecutive months.
If a pharmacy is selling more than 5% they should be
registered as a wholesale distributor
Source found here

Kansas Veterinary Rules Regarding Prescriptions

KANSAS ADMINISTRATIVE REGULATIONS
PUBLISHED APRIL 1997
Kansas Board Veterinary Examiners
Amendment/Addendum to the Kansas Administration Regulations

Article 7.--STANDARDS OF VETERINARY PRACTICE
70-7-1 The practice of veterinary medicine. Each veterinarian shall meet the following minimum standards in the practice of veterinary medicine.

***

(j) Controlled drugs. The veterinarian shall ensure that a separate written ledger is maintained when a controlled
drug is administered or dispensed.
(k) Locked area. If controlled drugs are used, the veterinarian shall ensure that a locked area for the storage
of controlled substances is provided.
(l) Dispensation of medications for companion animals.
(1) All prescription drugs to be dispensed for use by a companion animal may be dispensed only on the order of a licensed veterinarian who has an existing veterinary client-patient relationship as defined by the Kansas veterinary practice act. The veterinarian shall ensure that labels will be affixed to any unlabeled container containing any medication dispensed and to each factory-labeled container that contains prescription drugs or controlled substances dispensed for companion animals. The label shall be affixed to the immediate container and shall include the following information:
(A) The name and address of the veterinarian and, if the drug is a controlled substance, the veterinarian’s telephone number;
(B) the date of delivery or dispensing;
(C) the name of the patient, the client’s name, and, if the drug is a controlled substance, the client’s address;
(D) the species of the animal;
(E) the name, active ingredient, strength, and quantity of the drug dispensed;(F) directions for use specified by the practitioner including dosage, frequency, route of administration, and duration of therapy; and
(G) any cautionary statements required by law, including statements indicating that the drug is not for human consumption, is poisonous, or has withdrawal periods associated with the drug. If the size of the immediate container is insufficient to be labeled, the container shall be enclosed within another container large enough to be labeled.
(2) The term ‘‘companion animal’’ shall have the meaning specified in K.S.A. 47-816 and amendments thereto.
(m) Dispensation of medications for food or commercial animals. All prescription drugs to be dispensed for
food used by a food animal or used by a commercial animal may be dispensed only on a written order of a licensed veterinarian with an existing veterinary-client-patient relationship as defined by the Kansas veterinary practice act. That veterinarian shall maintain the original written order on file in the veterinarian’s office. A copy of the written order shall be on file with the distributor, and a second copy shall be maintained on the premises of the patient-client. The written order shall include the following information:
(1) The name and address of the veterinarian and, if the drug is a controlled substance, the veterinarian’s telephone number;

Raid closes alleged drug shop in Kansas

Posted on 17 August 2012. Tags: Chris Hoover, Drugs

Synthetic drugs like these, known as "Diablo," were seized by authorities at Blitzed Detox Shop at 5 E 7th Ave.

A local business was raided last Monday by Lyon County authorities and the Kansas Bureau of Investigation for alleged involvement in a synthetic drug ring. The KBI coordinated with local authorities to conduct a seven-month long investigation into the suspected sale of synthetic cannabinoids XR-11 and Ur-144, also known as potpourri, at Blitzed Detox Shop, located at 5 E. 7th Ave, and other business in Kansas.

To read the remainder of this blog entry click here.

Kansas: Pharmacy Law Update at Kansas Pharmacy Association Conference in September

At the Kansas Pharmacy Association conference on September 30, 2012, at 10:15am - noon Debra Billingsley, Executive Director, Kansas State Board of Pharmacy, will present a CE entitled Pharmacy Law Update.  To view entire schedule, click here.